Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active β-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c
The Rv3588c gene product of Mycobacterium tuberculosis, a β-carbonic anhydrase (CA, EC 4.2.1.1) denominated here mtCA 2, shows the highest catalytic activity for CO 2 hydration ( k cat of 9.8 × 10 5 s −1, and k cat/ K m of 9.3 × 10 7 M −1 s −1) among the three β-CAs encoded in the genome of this pat...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2009-12, Vol.19 (23), p.6649-6654 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The Rv3588c gene product of
Mycobacterium tuberculosis, a β-carbonic anhydrase (CA, EC 4.2.1.1) denominated here mtCA 2, shows the highest catalytic activity for CO
2 hydration (
k
cat of 9.8
×
10
5
s
−1, and
k
cat/
K
m of 9.3
×
10
7
M
−1
s
−1) among the three β-CAs encoded in the genome of this pathogen. A series of sulfonamides/sulfamates was assayed for their interaction with mtCA 2, and some diazenylbenzenesulfonamides were synthesized from sulfanilamide/metanilamide by diazotization followed by coupling with amines or phenols. Several low nanomolar mtCA 2 inhibitors have been detected among which acetazolamide, ethoxzolamide and some 4-diazenylbenzenesulfonamides (
K
Is of 9–59
nM). As the Rv3588c gene was shown to be essential to the growth of
M. tuberculosis, inhibition of this enzyme may be relevant for the design of antituberculosis drugs possessing a novel mechanism of action. |
---|---|
ISSN: | 0960-894X 1464-3405 1464-3405 |
DOI: | 10.1016/j.bmcl.2009.10.009 |